Stockreport

RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting

RenovoRx, Inc.  (RNXT) 
PDF Data supports the novel Trans-Arterial Micro-Perfusion (TAMPTM) therapy platform for targeted chemotherapy delivery for the potential to minimize a therapy’s toxicities [Read more]